6
Views
3
CrossRef citations to date
0
Altmetric
Journal Article

The lack of influence of long-term potassium citrate and calcium citrate treatment in total body aluminum burden in patients with functioning kidneys.

, , , &
Pages 102-106 | Published online: 04 Sep 2013

References

  • LoteCJ, SaundersH: Aluminum: Gastrointestinal absorption and renal excretion. Clin Sci 81: 289–295, 1991.
  • AlfreyAC: Aluminum metabolism. Kid Int 29 (Suppl. 18): S8–11, 1986.
  • MolitorisBA, FormentDH, MackenzieTA, HufferWH, AlfreyAC: Citrate: A major factor in the toxicity of orally administered aluminum compounds. Kid Int 36: 949–953, 1989.
  • FormentDH, MolitorisBA, BuddingtonB, MillerN, AlfreyAC: Site and mechanism of the gastrointestinal absorption of aluminum citrate in the rat. Kid Int 36: 978–985, 1989.
  • MartinRB: The chemistry of aluminum as related to biology and medicine. Clin Chem 32: 1797–1806, 1986.
  • Martinez-PalomaA, MezaI, BeatyG, CereijidoM: Experimental modulation of occluding junctions in cultured transporting epithelium. J Cell Biol 87: 736–745, 1980.
  • SakhaeeK, CopleyJB, PoindexterJR, AlexandridesG: Calcium citrate without aluminum antacids binds phosphate without enhancing aluminum absorption. (Abstract). Endocrine Society, 71st Annual Meeting 1153: 311, 1989.
  • SakhaeeK, WabnerCL, ZerwekhJE, CopleyJB, PakL, PoindexterJR, PakCYC: Calcium citrate without aluminum antacids does not cause aluminum retention in patients with functioning kidneys. Bone and Mineral 20: 87–97, 1993.
  • SakhaeeK, RumlL, PadalinoP, HaynesS, PakCYC: Assessment of skeletal aluminum (A1) stores by deferoxamine (DFO) test in patients undergoing long-term treatment with potassium citrate (K3 citrate) or calcium citrate (Ca3Cit2) ASN 4 (3) 701, 1993.
  • MallucheHH, SmithAJ, AbbeoK, FaugereMC: The use of deferoxamine in management of aluminum accumulation in bone in patients with renal failure. N Engl J Med 311: 140–144, 1984.
  • NebekerHG, AndressDL, MillinerDS, OttSM, AlfreyAC, SlatopolskyEA, SherrardDJ, CobumJW: Indirect methods for the diagnosis of aluminum bone disease: Plasma aluminum, the deferoxamine infusion test and serum iPTH. Kid Int 29 (Suppl): S96–S99, 1986.
  • EdwardsOM, BaylissRIS, MillenS: Urinary creatinine excretion as an index of completeness of 24-hour urine collection. Lancet ii: 1165–1166, 1969.
  • AldermanFR, GitelmanHJ: Improved electrothermal determination of aluminum in serum by atomic absorption spectroscopy. Clin Chem 26: 258–260, 1980.
  • PakCYC: Citrate and renal calculi. Min Elect Metab 13: 257–266, 1987.
  • SakhaeeK, NicarMJ, HillK, PakCYC: Contrasting effects of potassium citrate and sodium citrate therapies on urinary chemistries and crystallization of stone-forming salts. Kid Int 24: 348–352, 1983.
  • SakhaeeK, BakerS, ZerwekhJ, PoindexterJR, PakCYC: Limited risk of kidney stone formation during long-term calcium citrate supplementation in non-stone forming subjects. J Urol 152: 324–327, 1994.
  • SlaninaP, FrechW, BerhardsonA, CedergrenA, MattisonP: Influence of dietary factors on aluminum absorption and retention in the brain and bone of rats. Acta Pharmacol Toxicol 56: 331–336, 1985.
  • SlaninaP, FalkbomY, FrechW, CedergrenA: Aluminum concentration in the brain and bone of rats fed citric acid, aluminum citrate or aluminum hydroxide. Food Chem Toxicol 27: 391–397, 1984.
  • NolanCR, CalifanoJR, ButzinC: Influence of calcium acetate or calcium citrate on intestinal aluminum absorption. Kid Int 38: 937–941, 1990.
  • SlaninaP, FrechW, EkstromLG, LoofL, SlorachS, CedergrenA: Dietary citric acid enhances absorption on aluminum in antacids. Clin Chem 32: 539–541, 1986.
  • WalkerJA: Aluminum and citrate: A cautionary note. Semin Dialysis 1: 91–93, 1988.
  • LoteCJ, SaundersCH, WoodJA, SpencerAJ: Effect of citrate on plasma aluminum concentration and aluminum excretion in rat Clinical Science 83: 431–435, 1992.
  • SlatopolskyE: The interaction of parathyroid hormone and aluminum in renal osteodystrophy. Kid Int 31: 842–854, 1987.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.